期刊： MOLECULAR CARCINOGENESIS, 2023; 62 (12)
The atypical cadherin FAT1 function either as a pro or antitumorigenic in tumors of different tissue origins. Our group previously demonstrated the pr......
期刊： MOLECULAR CARCINOGENESIS, 2023; 62 (7)
Sprouty2 (SPRY2) is known to inhibit the RAS/MAPK/ERK pathway, and is a potential study target for cancer. The effect of SPRY2 in colorectal cancer (C......
期刊： MOLECULAR CARCINOGENESIS, 2023; 62 (8)
Molecular mechanisms of Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC) remain unclear in Japanese patients. Japanese EACs frequently hav......
期刊： MOLECULAR CARCINOGENESIS, 2023; 62 (3)
BackgroundHepatocellular Carcinoma (HCC) is a universal health problem responsible for 8.2% of all cancer deaths. Numerous risk factors were documente......
期刊： MOLECULAR CARCINOGENESIS, 2023; 62 (12)
An anticancer drug known as Rapamycin acts by inhibiting the mammalian target of the Rapamycin pathway. This agent has recently been investigated for ......
期刊： MOLECULAR CARCINOGENESIS, 2023; 62 (2)
Esophageal squamous cell carcinoma (ESCC) is highly resistant to chemoradiation therapy. We aimed to examine whether Nutlin-3, a molecule that suppres......
期刊： MOLECULAR CARCINOGENESIS, 2023; 62 (3)
Hepatocellular carcinoma (HCC) represents 90% of liver tumors. Statins may reduce HCC incidence. Its antitumor activities may be mediated by disruptin......
期刊： MOLECULAR CARCINOGENESIS, 2023; 62 (9)
Malnutrition has been reported to be associated with reduced survival and deficient anticancer immunity, and undernourishment is a frequent comorbidit......
期刊： MOLECULAR CARCINOGENESIS, 2023; 62 (7)
Endometrial cancer (EC) is the most common gynecologic malignancy in the world and incidence is steadily increasing. The Levonorgestrel Intrauterine S......
期刊： MOLECULAR CARCINOGENESIS, 2023; 62 (12)
Cellular retinoic acid binding protein 1 (CRABP1) participates in the regulation of retinoid signaling. Previous studies showed conflicting results re......
期刊： MOLECULAR CARCINOGENESIS, 2023; 62 (5)
Hepatocellular carcinoma (HCC) is one of the most worrying tumors worldwide today, and its epidemiology is on the rise. Traditional pharmacological ap......
